Мы используем файлы cookie.
Продолжая использовать сайт, вы даете свое согласие на работу с этими файлами.
Abandoned drugs
Estradiol benzoate/estradiol phenylpropionate
Другие языки:

    Estradiol benzoate/estradiol phenylpropionate

    Подписчиков: 0, рейтинг: 0
    Estradiol benzoate /
    estradiol phenylpropionate
    Estradiol benzoate.svg
    Estradiol phenylpropionate structure.svg
    Estradiol benzoate (top) and
    estradiol phenylpropionate (bottom)
    Combination of
    Estradiol benzoate Estrogen
    Estradiol phenylpropionate Estrogen
    Clinical data
    Trade names Dimenformon Prolongatum
    Other names EB/EPP; Org 369-2
    Routes of
    administration    		 Intramuscular injection
    Identifiers
    CAS Number
    PubChem CID
    ChemSpider
    UNII

    Estradiol benzoate/estradiol phenylpropionate (EB/EPP), sold under the brand name Dimenformon Prolongatum, is an injectable combination formulation of estradiol benzoate (EB), a shorter-acting estrogen, and estradiol phenylpropionate (EPP), a longer-acting estrogen, which has been used in menopausal hormone therapy for women in Europe but appears to no longer be available. It has also been used to suppress lactation in women and has been used in feminizing hormone therapy for transgender women. It has been provided in the form of 1 mL ampoules containing 2.5 mg EB and 10 mg EPP in oil solution and is administered by intramuscular injection at regular intervals.

    The pharmacokinetics of this formulation and its constituent components have been studied.

    A combination of 12.5 mg EB and 10 mg EPP (developmental code name Org 369–2) has been studied for use in women as a postcoital contraceptive within 48 hours of unprotected sex.

    See also



    Новое сообщение